Rosenblum Silverman Sutton’s Merck MRK Stock Holding History

Rosenblum Silverman Sutton’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,142	Closed	-$306K	–	66
2020 Q2	$306K	Hold	4,142	–	–	0.1%	56
2020 Q1	$304K	Hold	4,142	–	–	0.12%	61
2019 Q4	$359K	Sell	4,142 -67	-2%	-$5.5K	0.13%	52
2019 Q3	$338K	Hold	4,209	–	–	0.13%	51
2019 Q2	$337K	Sell	4,209 -141	-3%	-$10.8K	0.13%	49
2019 Q1	$345K	Sell	4,350 -82,043	-95%	-$6.14M	0.14%	52
2018 Q4	$8.37M	Buy	86,393 +82,462	+2,098%	+$5.82M	3.82%	8
2018 Q3	$266K	Buy	+3,931	New	+$250K	0.09%	62

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Rosenblum Silverman Sutton's MRK Position: Q3 2020 in Review

Rosenblum Silverman Sutton sold out of Merck (MRK) in Q3 2020, closing a stake of 4,142 shares — an estimated $306K sold.

Rosenblum Silverman Sutton first reported a position in MRK in Q3 2018 and held it in 8 quarters. The position peaked at $8.37M in Q4 2018. 2,558 funds tracked by Wall St. Rank hold MRK as of Q3 2020.

Rosenblum Silverman Sutton reported no remaining Merck position as of Q3 2020 after selling out during the quarter.
Rosenblum Silverman Sutton sold 4,142 Merck shares in Q3 2020, an estimated $306K.
Rosenblum Silverman Sutton first reported a position in Merck in Q3 2018 and held it in 8 quarters.
Rosenblum Silverman Sutton's Merck position peaked at $8.37M in Q4 2018.
2,558 funds tracked by Wall St. Rank held Merck as of Q3 2020.

Based on Rosenblum Silverman Sutton's 13F filing for Q3 2020, filed 9 Nov 2020.